Axial spondyloarthritis and inflammatory bowel disease: Therapeutic implications

被引:0
|
作者
Goupille, Philippe [1 ,2 ,6 ]
Vuitton, Lucine [3 ,4 ]
Wendling, Daniel [5 ]
机构
[1] CHU Tours, Rheumatol Dept, Tours, France
[2] Univ Tours, CNRS, UPR 4301, NMNS,CBM, Tours, France
[3] CHU Besancon, Gastroenterol Dept, Besancon, France
[4] Univ Franche Comte, Inserm, UMR RIGHT, Besancon, France
[5] Univ Franche Comte, CHU Besancon, Rheumatol Dept, EA 4266, Besancon, France
[6] CHU Tours, Trousseau Hosp, Rheumatol Dept, F-37044 Tours 9, France
关键词
Axial spondyloarthritis; Inflammatory bowel disease; Treatment; MAINTENANCE THERAPY; INDUCTION; GUIDELINES;
D O I
10.1016/j.jbspin.2024.105720
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [21] The genetics of inflammatory bowel disease: diagnostic and therapeutic implications
    Carmen Cuffari
    World Journal of Pediatrics, 2010, 6 : 203 - 209
  • [22] ENHANCING RHEUMATOLOGY REFERRALS AMONG INFLAMMATORY BOWEL DISEASE PATIENTS WITH SUSPECTED AXIAL SPONDYLOARTHRITIS
    Lim, C. S. E.
    Tremelling, M.
    Hamilton, L.
    Macgregor, A.
    Gaffney, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1134 - 1134
  • [23] Upadacitinib in a patient with concurrent refractory axial Spondyloarthritis and inflammatory bowel disease: A case report
    Li, Xingjian
    Pan, Xia
    Zheng, Shaoling
    Yi, Guanqun
    Zhong, Xiaoyan
    Zhang, Yuexi
    Huang, Zhengping
    Li, Tianwang
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (06)
  • [24] PREVALENCE OF UNDIAGNOSED AXIAL SPONDYLOARTHRITIS AMONG SECONDARY CARE PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Lim, C. S. E.
    Tremelling, M.
    Hamilton, L.
    MacGregor, A.
    Turmezei, T.
    Kim, M.
    Gaffney, K.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (05) : 1188 - 1188
  • [25] Frequency of axial spondyloarthritis in Tunisian patients with inflammatory bowel diseases
    Sahli, Hana
    Bachali, Asma
    Hamzaoui, Lamine
    Medhioub, Mouna
    Bachrouch, Aida
    Bouzaidi, Khaled
    Tekaya, Rawdha
    Azzouz, Msaddak
    EGYPTIAN RHEUMATOLOGIST, 2018, 40 (03): : 187 - 190
  • [26] Coagulation system and inflammatory bowel disease: Therapeutic and pathophysiologic implications
    Folwaczny, C
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2002, 40 (12): : 991 - 998
  • [27] Postbiotics in inflammatory bowel disease: efficacy, mechanism, and therapeutic implications
    Wang, Shuxin
    Wang, Pu
    Wang, Donghui
    Shen, Shenghai
    Wang, Shiqi
    Li, Yuanyuan
    Chen, Hao
    JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE, 2024,
  • [28] Therapeutic Implications of Phenolic Acids for Ameliorating Inflammatory Bowel Disease
    Lu, Yanan
    Han, Xue
    NUTRIENTS, 2024, 16 (09)
  • [29] THROMBOXANES IN INFLAMMATORY BOWEL-DISEASE - PATHOGENIC AND THERAPEUTIC IMPLICATIONS
    RAMPTON, DS
    COLLINS, CE
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1993, 7 (04) : 357 - 367
  • [30] Platelets in inflammatory bowel disease: Clinical, pathogenic, and therapeutic implications
    Danese, S
    de la Motte, C
    Fiocchi, C
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (05): : 938 - 945